T1	chemical 15 18	MPA
T2	chemical 47 54	hormone
T3	disease_or_phenotypic_feature 55 64	dependent
T4	disease_or_phenotypic_feature 100 117	renal cell cancer
T5	chemical 140 164	modified vaccinia Ankara
T6	chemical 187 194	antigen
T7	chemical 259 266	mineral
T8	chemical 267 272	water
T9	disease_or_phenotypic_feature 298 305	obesity
T10	chemical 346 349	PCG
T11	disease_or_phenotypic_feature 353 360	obesity
T12	disease_or_phenotypic_feature 365 372	obesity
T13	chemical 398 405	oxidant
T14	disease_or_phenotypic_feature 455 484	Hypogonadotropic hypogonadism
T15	chemical 489 503	growth hormone
T16	disease_or_phenotypic_feature 541 549	syndrome
T17	chemical 586 592	oxygen
T18	chemical 613 616	air
T19	disease_or_phenotypic_feature 642 648	anemia
T20	chemical 676 685	vitamin D
T21	disease_or_phenotypic_feature 698 717	atrial fibrillation
T22	chemical 802 809	hormone
T23	disease_or_phenotypic_feature 826 833	obesity
T24	chemical 835 842	17-DMAG
T25	chemical 847 862	Hsp90 inhibitor
T26	disease_or_phenotypic_feature 896 903	obesity
T27	chemical 989 994	group
T28	chemical 1013 1018	group
T29	disease_or_phenotypic_feature 1039 1045	injury
T30	chemical 1064 1069	group
T31	disease_or_phenotypic_feature 1111 1117	injury
T32	chemical 1211 1221	biological
T33	chemical 1283 1293	paclitaxel
T34	corrected_disease_or_phenotypic_feature 1334 1360;1369 1375	non-small cell lung cancer tumors
T35	corrected_disease_or_phenotypic_feature 1362 1367;1369 1375	NSCLC tumors
T36	chemical 1407 1413	enzyme
T37	chemical 1446 1455	galactose
T38	disease_or_phenotypic_feature 1494 1506	galactosemia
T39	disease_or_phenotypic_feature 1517 1526	cataracts
T40	disease_or_phenotypic_feature 1542 1560	growth retardation
T41	chemical 1585 1592	digoxin
T42	chemical 1596 1604	solution
T43	disease_or_phenotypic_feature 1643 1656	heart failure
T44	chemical 1659 1670	Biochemical
T45	disease_or_phenotypic_feature 1681 1699	mental retardation
T46	disease_or_phenotypic_feature 1703 1718	phenylketonuria
T47	chemical 1727 1733	oxygen
T48	disease_or_phenotypic_feature 1839 1848	essential
T49	disease_or_phenotypic_feature 1849 1856	obesity
T50	disease_or_phenotypic_feature 1885 1892	obesity
T51	chemical 1894 1904	Fluoxetine
T52	disease_or_phenotypic_feature 1938 1970	pervasive developmental disorder
T53	chemical 2004 2011	antigen
T54	disease_or_phenotypic_feature 2032 2059	medullary thyroid carcinoma
T55	chemical 2065 2073	androgen
T56	disease_or_phenotypic_feature 2181 2196	prostate cancer
T57	disease_or_phenotypic_feature 2256 2263	obesity
T58	chemical 2287 2297	biomarkers
T59	disease_or_phenotypic_feature 2299 2315	hyperinsulinemia
T60	disease_or_phenotypic_feature 2317 2330	hyperglycemia
T61	disease_or_phenotypic_feature 2413 2420	obesity
T62	chemical 2422 2432	anesthesia
R1	treats Arg1:T1 Arg2:T70	
R2	treats Arg1:T5 Arg2:T4	
T64	corrected_chemical 170 198	tumor-associated antigen 5T4
R3	treats Arg1:T64 Arg2:T4	
T65	corrected_chemical 246 272	Essentuskikh mineral water
R5	treats Arg1:T24 Arg2:T26	
R6	treats Arg1:T25 Arg2:T26	
R7	treats Arg1:T33 Arg2:T34	
R8	treats Arg1:T33 Arg2:T35	
R9	causes_or_contributes_to Arg1:T37 Arg2:T38	
T67	missed_disease_or_phenotypic_feature 1528 1541	liver lesions
R10	causes_or_contributes_to Arg1:T37 Arg2:T39	
R11	causes_or_contributes_to Arg1:T37 Arg2:T67	
R12	causes_or_contributes_to Arg1:T37 Arg2:T40	
T68	missed_disease_or_phenotypic_feature 1918 1934	selective mutism
R14	treats Arg1:T51 Arg2:T68	
T70	missed_disease_or_phenotypic_feature 65 71	tumors
R15	causes_or_contributes_to Arg1:T2 Arg2:T70	
R13	treats Arg1:T41 Arg2:T43	
T69	missed_disease_or_phenotypic_feature 2198 2200	PC
T63	missed_disease_or_phenotypic_feature 787 801	Postmenopausal
R18	treats Arg1:T22 Arg2:T63	
R19	treats Arg1:T51 Arg2:T52	
